Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer (NCT02517034)
Advancing Screening and Treatment for Older Patients With Cancer
🩺 Plain-English Summary (8th-Grade Level)
This randomized clinical trial studies a geriatric assessment intervention in predicting chemotherapy toxicity and vulnerabilities (or weakness) in older patients with cancer. Assessing patients' functional status, comorbidities, psychological state, social support, nutritional status, and cognitive function before treatment may help identify vulnerabilities, improve care, and decrease chemotherapy side effects in older patients with cancer.
Who can join: Review the eligibility criteria below.
Location: City of Hope Medical Center — Duarte, California
Age range: 65 Years
🧪 Interventions in This Study
- Comprehensive Geriatric Assessment (OTHER)
- Quality-of-Life Assessment (OTHER)
- Questionnaire Administration (OTHER)
- Survey Administration (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- City of Hope Medical Center — Duarte, California
- City of Hope Antelope Valley — Lancaster, California
- City of Hope Rancho Cucamonga — Rancho Cucamonga, California
- City of Hope South Pasadena — South Pasadena, California
- City of Hope West Covina — West Covina, California
📞 Contact the Study Coordinator
Phone: (800) 826-4673
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Solid Neoplasm
- Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors — Jacksonville, Florida
Explore by condition: All Solid Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.